NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 199 filers reported holding NEKTAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,019,000 | +71.1% | 164,574 | +139.6% | 0.00% | +100.0% |
| Q3 2016 | $1,180,000 | -85.3% | 68,686 | -87.8% | 0.00% | -87.5% |
| Q2 2016 | $8,005,000 | -75.0% | 562,552 | -75.9% | 0.01% | -76.5% |
| Q1 2016 | $32,083,000 | -18.7% | 2,333,340 | -0.4% | 0.03% | -19.0% |
| Q4 2015 | $39,466,000 | +56.8% | 2,342,182 | +2.0% | 0.04% | +55.6% |
| Q3 2015 | $25,176,000 | +53.6% | 2,297,091 | +75.3% | 0.03% | +58.8% |
| Q2 2015 | $16,391,000 | +1733.4% | 1,310,241 | +1512.5% | 0.02% | +1600.0% |
| Q1 2015 | $894,000 | -16.8% | 81,253 | +17.2% | 0.00% | 0.0% |
| Q4 2014 | $1,074,000 | +22.7% | 69,308 | -4.4% | 0.00% | 0.0% |
| Q3 2014 | $875,000 | -7.6% | 72,515 | -1.9% | 0.00% | 0.0% |
| Q2 2014 | $947,000 | -61.8% | 73,884 | -63.9% | 0.00% | -50.0% |
| Q1 2014 | $2,482,000 | +191.7% | 204,776 | +173.0% | 0.00% | +100.0% |
| Q4 2013 | $851,000 | +17.2% | 75,005 | +7.9% | 0.00% | 0.0% |
| Q3 2013 | $726,000 | -9.4% | 69,539 | +0.2% | 0.00% | 0.0% |
| Q2 2013 | $801,000 | – | 69,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |